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Objective: To explore the expression of microRNA (miRNA) let-7c and its function in
chronic obstructive pulmonary disease (COPD) and alveolar macrophage cells.
Methods: Real time PCR was performed to detect the expression of miRNA let-7c in the
lung tissue of COPD patients and COPD model in mice. MiRNA let-7c was overexpressed
in alveolarmacrophages isolated frommice and its effectwasmeasured by the production of
pro-inﬂammation cytokines and the protein level of signal transducer and activator of
transcription 3 (STAT3) as well as phosphorylation level of STAT3 after LPS stimulation.
Luciferase assay was used to detect the binding of miRNA let-7c and 30UTR of STAT3.
Results: MiRNA let-7c expression was signiﬁcantly lower in patients with COPD
compared with control group, and the similar result was found in COPD mice and LPS
stimulated alveolar macrophages. Overexpression of miRNA let-7c in alveolar macro-
phages inhibited LPS-induced increasing of tumor necrosis factor alpha, interleukin-6 and
interleukin-1b. Luciferase assay showed STAT3 was a targeting of miRNA let-7c in
alveolar macrophages.
Conclusions: MiRNA let-7c low expression in COPD can regulate inﬂammatory re-
sponses by targeting STAT3 in alveolar macrophage, which may provide a new target for
COPD treatment strategies.1. Introduction
Chronic obstructive pulmonary disease (COPD), a high
morbidity and mortality pulmonary disease characterized by
chronic airway inﬂammation and emphysematous alveolar
destruction, may develop into pulmonary heart disease, respi-
ratory failure and even cancer [1]. Due to the high morbidity and
mortality, COPD has become one of the world's three major
lethal factors, which brings a heavy burden to the society and
a serious threat to the quality of human life [2,3]. Although
smoking has been considered an important COPD risk factor,
only a small portion of smokers (10%–20%) eventually
develop into COPD [4]; its pathogenesis remains to be further
studied. The development of COPD must be affected by other
factors, such as genetic factors.
Abundant evidences show that the development of COPD is
associatedwith systemic inﬂammation and chronic inﬂammatory in
the bronchial walls of the small airways. Inﬂammation isconsidered to be a markedly increased risk of cardiovascular dis-
ease and lung cancer in patients with COPD [5]. Both innate and
adaptive immunity is involved in COPD. Plenty of inhibitors of
inﬂammation show potential beneﬁcial effects in COPD. A large
number of studies show that participation in the pathogenesis of
COPD is associated with a variety of inﬂammatory cells [6–10], of
which the most important are the macrophages, the neutrophils
and the lymphocytes. Alveolar macrophages and the release of
cytokines play an important role in the pathogenesis of COPD
[10]. The present study was designed to investigate the expression
of microRNA (miRNA) let-7c in COPD and its role in alveolar
macrophage and inﬂammatory response.
2. Materials and methods
2.1. Animal model
In this study, 40 clean male BALB/C mice were used to
build COPD model, 6–8 wk old, weighing 18–20 g. Mice were
purchased from Experimental Animal Center of Chongqing
Medical University. The animals were randomly divided into
control group and COPD model group. Model group were
exposed to cigarette smoke, 10 cigarettes per day for 1 h,rticle under the CC BY-NC-ND license (http://
Table 1
Expression of microRNA let-7c in alveolar macrophages.
Group Let-7c relative expressison
Control 1.083 ± 0.348
COPD 0.356 ± 0.039*
*P < 0.05, compared with control.
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carried out in accordance with the Guide for the Care and Use
of Laboratory Animals and were approved by the Chinese
National Committee to the Use of Experimental Animals for
Medical Purposes.
2.2. Cell culture
COPD and normal mice were sacriﬁced by cervical dislo-
cation and bronchial alveolar lavage ﬂuid was collected, fol-
lowed by centrifugation at 2000 rpm for 10 min. Supernatant
was discarded and cells was suspended by RPMI 1640 medium
containing 10% fetal calf serum, incubated in 37 C, 5% CO2
incubator for 3 h. After that medium was changed to remove the
non-adherent cells, and the adherent alveolar macrophages were
re-digested and counted; the puriﬁed alveolar macrophages were
ready to be used.
2.3. Plasmids construction and luciferase assays
Signal transducer and activator of transcription 3 (STAT3)
30-UTR containing let-7c binding site was cloned into a
modiﬁed pGL3 vector (Promega, Madison, WI, USA) con-
taining the luciferase gene. Mutations in the 30-UTR of STAT3
gene with lect-7c target sites deleted was generated with the
QuickChange Site-Directed Mutagenesis kit (Stratagene, CA,
USA). About 1 × 105 alveolar macrophages per well were
seeded into 24-well plates and co-transfected with 50 ng pGL3
ﬁreﬂy luciferase reporter, 10 ng pRL-TK luciferase reporter
and 50 nM let-7c mimics or scramble mimics using Lipofect-
amine 2000 (Invitrogen, Carlsbad, CA, USA). Cell lysates
were prepared using Passive Lysis Buffer (Promega, Madison,
WI, USA) 48 h after transfection, and luciferase activity was
measured using the Dual-Luciferase Reporter Assay (Promega,
Madison, WI, USA).
2.4. Real time PCR
Total RNA was extracted from tissues and cells by Trizol
according to the manufacturer's instructions. Reverse tran-
scription of 1 mg of total RNA was performed using Takara
reverse transcription kit. Expression of individual genes was
then analyzed by semi-quantitative qRT-PCR using SYBR
green technology in ABI Prism Sequencher 7500 (Applied
Biosystems, Foster City, CA, USA). Let-7c expression was
measured by using the TaqMan MiRNA Assay with speciﬁc
primers for hsa-let-7c. U6 snRNA was used for normalization
of the relative abundance of let-7c. Speciﬁc probe was designed
and synthesized by Lifescience. Primer pairs for tumor necrosis
factor alpha (TNF-a) sense: 50-CAT CTT CTC AAA ATT CGA
GTG ACA A-30, antisense: 50- CCA GCT GCT CCT CCA CTT
G-30; interleukin (IL)-6 sense: 50- CAC AGA GGA TAC CAC
TCC CAA CA-30, antisense: 50- TCC ACG ATT TCC CAG
AGA ACA-30; IL-1b sense: 50- AAG CCT CGT GCT GTC
GGA CC-30, antisense: 50- TGA GGC CCA AGG CCA CAG
GT-30;b-actin was ampliﬁed using the following primer: sense:
50- CGT GAA AAG ACC CAG ATC A-30, antisense: 50- CAC
AGC CTG GAT GGC TAC GT-30. The mRNA expression of
TNFa, IL-1b and IL-6 was normalized versus b-actin mRNA.
The relative expression was quantiﬁed with the 2-DDCt
method. Experiments were independently repeated at least three
times.2.5. Western blot analysis
After the cells were harvested, 1 × RIPA buffer containing
protease and phosphatase inhibitors was used to lysate cells.
Polyacrylamide gel electrophoresis was performed after addi-
tion of SDS loading buffer and boiled for 5 min, and then
proteins was transferred to a PVDF membrane (Milipore).
After blocked by 5% non-fat milk at room temperature, pri-
mary antibody was incubated overnight at 4 C (1: 1000),
followed by incubation with horseradish peroxidase-coupled
secondary antibody, and target band was detected by chem-
iluminescence. Protease inhibitors and phosphatase inhibitors
were purchased from Roche Company; rabbit antibody against
STAT3 p-STAT3 were purchased from Cell Signaling Tech-
nology; mouse antibody against b-actin was purchased from
Santa Cruz Biotechnology; chemiluminescence were pur-
chased from Thermo Pierce.
2.6. Statistical analysis
All data were shown as the mean ± standard deviation of
three or more independent experiments. Results were analyzed
using SPSS 18.0 software (SPSS, Chicago, IL, USA) and
PRISM 6 (GraphPad Software Inc., San Diego, CA, USA).
P < 0.05 was regarded as statistically signiﬁcant.
3. Results
3.1. Expression of miRNA let-7c in COPD
The cells from alveolar macrophages in the BALF of mice
with COPD were isolated and total RNA was extracted to detect
the expression level of microRNA let-7c. Real-time PCR
showed that the level of let-7c in alveolar macrophages of mice
with COPD was signiﬁcantly lower than the normal mice
(Table 1).
3.2. MiRNA let-7c expression in LPS treated alveolar
macrophages
To further explore the potential role of let-7c in COPD, the
cells from alveolar macrophages in the bronchial alveolar lavage
ﬂuid of mice with COPD were isolated. In addition, alveolar
macrophages form normal mice were treated with 100 ng/mL
LPS for 6 h, 12 h and 24 h. we also found that inﬂammatory
cytokines TNF-a, IL-1b, and IL-6 expression were signiﬁcantly
up-regulated, while the expression of let-7c was signiﬁcantly
down-regulated (Table 2).
3.3. Inhibition of LPS-induced pro-inﬂammation
cytokines production by let-7c
To further investigate the function of let-7c in alveolar mac-
rophages, let-7c mimics were synthesized and transfected into
Table 2
Expression of let-7c and cytokines in LPS treated alveolar macrophages.
Group Control group 6 h 12 h 24 h
Let-7c 1.021 ± 0.242 0.532 ± 0.121* 0.195 ± 0.024* 0.253 ± 0.031*
TNF-a 1.127 ± 0.032 5.351 ± 0.284* 6.723 ± 0.521* 6.272 ± 0.807*
IL-1b 1.097 ± 0.018 6.351 ± 0.412* 9.230 ± 1.031* 12.313 ± 2.24*
IL-6 1.023 ± 0.062 4.826 ± 0.234* 6.237 ± 0.523* 5.826 ± 1.231*
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expression of let-7c was greatly boosted after transfected with let-
7c mimics but not in non-speciﬁc small RNA fragments trans-
fected cells. After transfection, alveolar macrophages were treated
with LPS for 12 h; it was found that high expression of TNFa, IL-
1b and IL-6 induced by LPS was signiﬁcantly suppressed by let-
7c. In addition, the phosphorylation level of STAT3, a critical
transcription factor in inﬂammatory signaling pathways that could
always be activated, was also inhibited by overexpression of
let-7c.
3.4. Suppression of phosphorylation of STAT3 by let-7
To understand the mechanism of down-regulation of p-
STAT3 in alveolar macrophages by let-7c, the target gene of let-
7c was predicted (http://www.microrna.org). Interestingly, we
found that STAT3 was predicted to be a potential target of let-7c.
Therefore, we conducted luciferase reporter assays with STAT3
30-UTR in let-7c or scramble mimic transfected alveolar mac-
rophages. A signiﬁcant decrease of luciferase activity upon let-
7c transfection was observed, suggesting that let-7c suppressed
STAT3 directly in alveolar macrophages. In addition, we also
found protein and mRNA expression levels of STAT3 were
signiﬁcantly decreased in let-7c transfected cells.4. Discussion
MiRNAs, a class of short single-stranded RNA molecules
(19- to 25-nucleotide) that negatively regulate gene expression at
the post-transcriptional level, play an important regulatory role
in many biological processes, including inﬂammation, cellular
proliferation, differentiation, and apoptosis. MiRNAs have been
implicated in the pathogenesis of asthma, lung ﬁbrosis and lung
cancer by targeting transcription factors [11–13]. Here, we
reported miRNA let-7c was signiﬁcantly lower in patients with
COPD compared with healthy subjects, especially in alveolar
macrophages. Restored expression of miRNA let-7c in alveolar
macrophages could partially reversed LPS induced inﬂammatory
reaction by inhibiting the phosphorylation of STAT3.
Let-7, the ﬁrst known human miRNA, was originally
discovered by Reinhart in 2000 [14]. Let-7 comprise one of the
largest family of miRNAs in human, including let-7a-1, let-7a-2,
let-7a-3, let-7b, let-7c, let-7d, let-7e, let-7f-1, let-7f-2, let-7g, let-
7i, miR-98, and miR-202 [15]. Let-7 miRNAs have been reported
to be critical for promoting differentiation and inhibiting cellular
proliferation and its down-regulation has been found in many
cancers, including breast cancers, prostate cancer and lung
cancer [16–18]. In the present study, we found let-7c was obvi-
ously lower in patients with COPD in comparison with healthy
subjects, and the similar results was observed in mice model,
which was consistent with the results reported by Van Pottel-
berge [19].It is well known that COPD is characterized by chronic airway
inﬂammation and emphysematous alveolar destruction. The
inﬂammation is heterogeneous and involved with macrophages,
neutrophils and T cells [5]. Macrophages are believed to play a key
role in the pathogenesis of COPD and found markedly increase in
numbers with increasingly strong inﬂammatory response, in both
the airways and lung parenchyma [20,21]. Interestingly, we found
let-7c was greatly decreased in alveolar macrophages in mice
with COPD compared with control group. Down-regulation of let-
7c was also found in isolated alveolar macrophages with LPS
stimulation. To assess the effect of let-7c, alveolar macrophages
were isolated and transfected with let-7c mimic or scramble
shRNA. We observed that overexpression of let-7c suppressed
increasing of important pro-inﬂammation cytokines produced by
alveolar macrophages after exposed to LPS, including TNFa, IL-
1b and IL-6. These results suggested that let-7c might play an anti-
inﬂammation role in alveolar macrophages.
STAT3 is an important mediator of the inﬂammatory
response. Once activated, STAT3 migrates to the nucleus, ac-
tivates transcription of downstream genes in a sequence-
speciﬁc manner and plays a role in cell proliferation, inhibi-
tion of apoptosis and inﬂammatory response. The phosphory-
lation of STAT3 was enhanced in alveolar macrophages post
LPS stimulation inhibited by the expression of let-7c. We
found the putative binding site of let-7c in STAT3 30-UTR by
the biological prediction program. Luciferase reporter assays
showed that overexpression of let-7c caused a huge reduction
of luciferase activity by the luciferase expression constructs
carrying the target STAT3 30-UTR fragment but no difference
was observed on STAT3 30-UTR mutated fragment. Also, the
protein and mRNA expression of STAT3 were signiﬁcantly
decreased after transfected with let-7c mimic demonstrating
that let-7c can directly target STAT3 mRNA in alveolar
macrophages.
In conclusion, let-7c is signiﬁcantly lower in patients with
COPD and might function as a negative regulator of the in-
ﬂammatory response in alveolar macrophages by inhibiting the
expression and phosphorylation of STAT3. This ﬁnding not
only helps understand the role and mechanism of miRNA in
inﬂammation, but also provides foundation for the development
of targeted inhibitors of inﬂammation in COPD.
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